Drug
Cdx 1307 Vaccine Regimen
Cdx 1307 Vaccine Regimen: highest development phase Phase 2, developed by Celldex Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Celldex Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| CDX-1307 Vaccine Regimen NCT01094496 | Phase 2 | Bladder Cancer |
Latest
No recent events.
Follow Cdx 1307 Vaccine Regimen on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.